Showing results (301-310 of 444) with videos related to

Sort By:
Pageof 45
Oncotarget|May 4, 2017
The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosisFranco Conforti, Elizabeth R Davies, Claire J Calderwood, et al.
The Lancet. Respiratory Medicine|December 3, 2014
Combination therapy: the future of management for idiopathic pulmonary fibrosis?Wim A Wuyts, Katerina M Antoniou, Keren Borensztajn, et al.
Chest|November 7, 2016
Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity PneumonitisJulie Morisset, Kerri A Johannson, Eric Vittinghoff, et al.
Chest|February 9, 2013
Radiographic fibrosis score predicts survival in hypersensitivity pneumonitisJoshua J Mooney, Brett M Elicker, Thomas H Urbania, et al.
The Lancet. Respiratory Medicine|August 4, 2018
Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trialsMargaret Neighbors, Christopher R Cabanski, Thirumalai R Ramalingam, et al.
Diagnostics (Basel, Switzerland)|September 5, 2020
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist InvolvementEnrico De Lorenzis, Silvia Laura Bosello, Francesco Varone, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trialJustin M Oldham, Arata Azuma, Michael Kreuter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 5, 2005
Urinary and plasma organic acids and amino acids in chronic fatigue syndromeMark G Jones, Elizabeth Cooper, Saira Amjad, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|June 22, 2026
Bone involvement in sarcoidosis: Insights from a multicentre Italian cohortTommaso Pianigiani, Elisa Bianchi, Giulio Natalello, et al.
Plos One|July 1, 2016
miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary FibrosisSupparerk Disayabutr, Eun Kyung Kim, Seung-Ick Cha, et al.
Pageof 45